- Alzheimer’s Disease Has At Least Five Variants, Possibly Explaining Treatment Failures IFLScience
- Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles Nature.com
- Dutch scientists uncover five different biological variants of Alzheimer’s disease News-Medical.Net
- Different biological variants discovered in Alzheimer’s disease Medical Xpress
- Scientists discover there’s FIVE types of Alzheimer’s and are hopeful breakthrough could lead to cure Daily Mail
Tag Archives: treatment
Spokane doctor’s kidney treatment will be tested in 11000-person study – The Seattle Times
- Spokane doctor’s kidney treatment will be tested in 11000-person study The Seattle Times
- Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial The Lancet
- ‘On par with the biggest breakthroughs in medicine’: Spokane doctor discovers new kidney disease treatment. An 11000-person study will start in 2024 The Spokesman Review
- Significant benefit seen in Phase III trial of experimental drug for kidney disease Medical Xpress
- Kidney Disease Drug Candidate Shows Broad Inhibition of Damaging Hormone Inside Precision Medicine
Vertex Announces Positive Results From Phase 2 Study of VX-548 for the Treatment of Painful Diabetic Peripheral Neuropathy | Vertex Pharmaceuticals Newsroom – news.vrtx.com
- Vertex Announces Positive Results From Phase 2 Study of VX-548 for the Treatment of Painful Diabetic Peripheral Neuropathy | Vertex Pharmaceuticals Newsroom news.vrtx.com
- Vertex shares pop after nonopioid painkiller posts positive midstage trial results CNBC
- Vertex Pharmaceuticals Jumps on Pain Medication Success: How to Play It RealMoney
- Vertex Rallies, Flashes Bullish Signal On Phase 2 Results For Opioid Alternative Investor’s Business Daily
- Vertex passes neuropathic pain test, teeing up pivotal trials in pursuit of blockbuster opportunity FierceBiotech
Israeli Captives Smile, Wave Goodbye To Al-Qassam Captors; Thank Hamas For Kind Treatment | Watch – Hindustan Times
- Israeli Captives Smile, Wave Goodbye To Al-Qassam Captors; Thank Hamas For Kind Treatment | Watch Hindustan Times
- Israel angered over footage depicting Hamas’ treatment of released Israeli hostages Anadolu Agency | English
- Must Watch: Jokes, smiles, handshakes & hugs! Unusual bonding between Hamas terrorists and hostages Times of India
- Qassam Fighters Hug, Give High-Five To Israeli & Thai Hostages In Gaza | ‘Good Luck, Shukran’ Hindustan Times
- Islamic Jihad seen playing Hamas wingman at hostage handoff The Times of Israel
- View Full Coverage on Google News
Clinical trials suggest first-ever safe and effective treatment to prevent multidrug-resistant TB in children and adults – Medical Xpress
- Clinical trials suggest first-ever safe and effective treatment to prevent multidrug-resistant TB in children and adults Medical Xpress
- Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial The Lancet
- Indian drugmaker to supply key component of drug-resistant TB regimens University of Minnesota Twin Cities
- Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options Doctors Without Borders
- View Full Coverage on Google News
Clinical trials suggest first-ever safe and effective treatment to prevent multidrug-resistant TB in children and adults – Medical Xpress
- Clinical trials suggest first-ever safe and effective treatment to prevent multidrug-resistant TB in children and adults Medical Xpress
- Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial The Lancet
- Levofloxacin could be a cheap solution to drug-resistant tuberculosis, studies say Yahoo Singapore News
- Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options Doctors Without Borders
- View Full Coverage on Google News
‘Should think of consequences …’: Taliban warns Pakistan against ‘cruel’ treatment of Afghans – IndiaTimes
- ‘Should think of consequences …’: Taliban warns Pakistan against ‘cruel’ treatment of Afghans IndiaTimes
- Pakistan orders expulsion of hundreds of thousands of Afghan refugees The Washington Post
- Afghans fleeing Pakistan lack water, food and shelter once they cross the border, aid groups say The Associated Press
- Pakistan deports more than 6,500 Afghans; total repatriated to Afghanistan touches 1,70,000: Official The Hindu
- How China can stop Pakistan from worsening Afghanistan’s humanitarian crisis South China Morning Post
- View Full Coverage on Google News
‘Doctors told me I had terminal breast cancer at 35… and I said NO to treatment’: Given six months to live, Ka – Daily Mail
- ‘Doctors told me I had terminal breast cancer at 35… and I said NO to treatment’: Given six months to live, Ka Daily Mail
- UK mum Katie Barson reveals why she wanted to ‘do life without the side effects of chemo’ New Zealand Herald
- Nurse tried to brush off ‘mark on her tights’ before learning it was sign of cancer The Mirror
- ‘I’m living with incurable cancer – and as long as I can do the school run, I know I’m doing ok’ Bishop’s Stortford Independent
- Woman’s dreams of having children crushed after being told breast cancer had spread and is incurable RSVP Live
- View Full Coverage on Google News
FDA approves Eli Lilly ulcerative colitis treatment Omvoh – STAT – STAT
- FDA approves Eli Lilly ulcerative colitis treatment Omvoh – STAT STAT
- Lilly’s bowel disease drug gets US FDA nod for treatment in adults Reuters
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company Investors | Eli Lilly and Company
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis PR Newswire
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis Yahoo Finance
- View Full Coverage on Google News
FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company – Investors | Eli Lilly and Company
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company Investors | Eli Lilly and Company
- Lilly’s bowel disease drug gets US FDA nod for treatment in adults Reuters
- FDA approves Eli Lilly ulcerative colitis treatment Omvoh – STAT STAT
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis PR Newswire
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis Yahoo Finance
- View Full Coverage on Google News